AbbVie bows to pressure to keep cheaper Imbruvica formula on the market

AbbVie bows to pressure to keep cheaper Imbruvica formula on the market

Source: 
Fierce Pharma
News Tags: 
snippet: 

When AbbVie introduced a single-tablet version of its blood cancer drug Imbruvica earlier this year, it pitched the new formula as easier and more convenient for patients who took the older version as often as four times a day.